Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Leukemia, Myeloid, Acute 42Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Myelodysplastic Syndromes 33Leukemia, Myelogenous, Chronic, BCR-ABL Positive 20Myeloproliferative Disorders 18Leukemia, Biphenotypic, Acute 18Hematologic Neoplasms 18Leukemia, Lymphocytic, Chronic, B-Cell 16Lymphoma, Non-Hodgkin 15Hodgkin Disease 15Multiple Myeloma 14Leukemia, Myelomonocytic, Chronic 13Leukemia 12Anemia, Refractory, with Excess of Blasts 11Primary Myelofibrosis 10Lymphoma, Follicular 10Lymphoma, Mantle-Cell 9Burkitt Lymphoma 9Lymphoma, B-Cell, Marginal Zone 8Lymphoma 8Lymphoma, T-Cell 7Leukemia, Prolymphocytic 7Anemia, Aplastic 7Leukemia, Myeloid 6Graft vs Host Disease 6Waldenstrom Macroglobulinemia 5Polycythemia Vera 5Lymphoma, Large B-Cell, Diffuse 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Myeloid, Accelerated Phase 4

Interventions

thymoglobulin 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Stem Cell Transplantation 1Sirolimus 1Mycophenolic Acid 1Hematopoietic Stem Cell Transplantation 1Cyclophosphamide 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Non-Malignant Neoplasm × Whole-Body Irradiation × 1 year × Clear all
NCT04083183 2025-12-18

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
40 enrolled
Other neoplasm

Non-Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡